____ _ _ _ _
| _ \ ___ | |_ (_) _ __ ___ __| | (_) __ _
| |_) | / _ \ | __| | | | '_ \ / _ \ / _| | | | / _ |
| _ < | __/ | |_ | | | |_) | | __/ | (_| | | | | (_| |
|_| \_\ \___| \__| |_| | .__/ \___| \__,_| |_| \__,_|
|_|
- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b- `b
Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―Β―
Poly I:C
ββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ
top
Contents
β’ Eigenschaften
β’ Einzelnachweise
ββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ
Eigenschaften
Poly I:C besteht aus zwei polymeren StrΓ€ngen von LΓ€ngen zwischen 1,5 und 8 kb,cite-ref-3[3] einem Poly-InosinsΓ€ure- und einem Poly-CytidinsΓ€ure-Strang, die ΓΌber WasserstoffbrΓΌckenbindungen aneinander binden und einen Doppelstrang bilden. Poly I:C bindet in Tieren an den Toll-like Receptor 3 (TLR-3) und aktiviert ihn, wodurch in Folge die angeborene Immunantwort aktiviert wird.cite-ref-4[4] TLR-3 wird von B-Zellen, Makrophagen und dendritischen Zellen gebildet. Der ATC-Code von Poly I:C ist L03AX07.cite-ref-5[5] In Folge der Aktivierung des TLR-3 durch Poly I:C werden Interferone des Typs I gebildet.cite-ref-yoshida-6-0[6]
Poly I:C wird als Adjuvans bei Impfstoffencite-ref-11[11]cite-ref-pmid34288795-12-0[12] und zur Induktion einer Apoptose in Krebszellen untersucht.cite-ref-13[13] Ein alternativer Agonist des TLR-3 ist RGC100, ein Poly-GuanylsΓ€ure:Poly-CytidinsΓ€ure-Doppelstrang mit geringerer ToxizitΓ€t und ungefΓ€hr 100 Basenpaaren LΓ€nge, da von TLR-3 nur die wiederholenden Ribose-Einheiten sequenzunabhΓ€ngig gebunden werden und eine Aktivierung bereits ab etwa 45 Basenpaaren erfolgt.cite-ref-naumann-14-0[14]
Einzelnachweise
cite-note-11. Datenblatt Polyinosinicβpolycytidylic acid potassium salt bei Sigma-Aldrich, abgerufen am 15. Juli 2020 (PDF).
cite-note-smorodintsev-22. A. A. Smorodintsev, O. A. Aksenov, I. K. Konstantinova, L. M. Vil'ner, A. V. Tinufanov: [Comparative study of the toxicity of poly G-poly C and poly I-poly C in different objects]. In: Voprosy virusologii. Nummer 2, 1978 Mar-Apr, S. 201β206, PMID 664621.
cite-note-33. β H. Kato, O. Takeuchi, E. Mikamo-Satoh, R. Hirai, T. Kawai, K. Matsushita, A. Hiiragi, T. S. Dermody, T. Fujita, S. Akira: Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. In: The Journal of Experimental Medicine. Band 205, Nummer 7, Juli 2008, S. 1601β1610, doi:10.1084/jem.20080091, PMID 18591409, PMC 2442638 (freier Volltext).
cite-note-44. β Y. Li, X. L. Xu, D. Zhao, L. N. Pan, C. W. Huang, L. J. Guo, Q. Lu, J. Wang: TLR3 ligand Poly IC Attenuates Reactive Astrogliosis and Improves Recovery of Rats after Focal Cerebral Ischemia. In: CNS Neuroscience & Therapeutics. Band 21, Nummer 11, November 2015, S. 905β913, doi:10.1111/cns.12469, PMID 26494128, PMC 4638223 (freier Volltext).
cite-note-pmid18591409-77. β H. Kato, O. Takeuchi, E. Mikamo-Satoh, R. Hirai, T. Kawai, K. Matsushita, A. Hiiragi, T. S. Dermody, T. Fujita, S. Akira: Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. In: The Journal of Experimental Medicine. Band 205, Nummer 7, Juli 2008, S. 1601β1610, doi:10.1084/jem.20080091, PMID 18591409, PMC 2442638 (freier Volltext).
cite-note-pmid26283481-88. β N. Dauletbaev, M. Cammisano, K. Herscovitch, L. C. Lands: Stimulation of the RIG-I/MAVS Pathway by Polyinosinic:Polycytidylic Acid Upregulates IFN-Ξ² in Airway Epithelial Cells with Minimal Costimulation of IL-8. In: Journal of immunology. Band 195, Nummer 6, September 2015, S. 2829β2841, doi:10.4049/jimmunol.1400840, PMID 26283481.
cite-note-pmid25568326-1010. β S. Palchetti, D. Starace, P. De Cesaris, A. Filippini, E. Ziparo, A. Riccioli: Transfected poly(I:C) activates different dsRNA receptors, leading to apoptosis or immunoadjuvant response in androgen-independent prostate cancer cells. In: Journal of Biological Chemistry. Band 290, Nummer 9, Februar 2015, S. 5470β5483, doi:10.1074/jbc.M114.601625, PMID 25568326, PMC 4342463 (freier Volltext).
cite-note-pmid34288795-1212. β G. G. Guerrero Manriquez, I. Tuero: Adjuvants: friends in vaccine formulations against infectious diseases. In: Human vaccines & immunotherapeutics. Band 17, Nummer 10, Oktober 2021, S. 3539β3550, doi:10.1080/21645515.2021.1934354, PMID 34288795, PMC 8437479 (freier Volltext) (Review).
cite-note-naumann-1414. β K. Naumann, R. Wehner, A. Schwarze, C. Petzold, M. Schmitz, J. Rohayem: Activation of dendritic cells by the novel Toll-like receptor 3 agonist RGC100. In: Clinical & Developmental Immunology. Band 2013, 2013, S. 283649, doi:10.1155/2013/283649, PMID 24454470, PMC 3878805 (freier Volltext).